Success Stories: A Postdoctoral Fellow in Biomedical Sciences with a Ph.D. in Molecular Oncology Gets NIW Approval with Our Team Effort
Client’s Testimonial:
“Thank you so much for the good news.”
On November 18th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Italy
State of Residence at the Time of Filing: New York
Approval Notice Date: November 18th, 2021
Processing Time: 11 months, 24 days
Case Summary:
An expert in the field of biomedical sciences, our client from Italy wanted our help to file his NIW (National Interest Waiver) application. The NIW category requires the applicants to prove beyond reasonable doubt the ongoing value of their work for the United States. It is only then that the USCIS decides whether to waive the labor certification for the petitioners or not. So our job was cut out for us from the very beginning. We needed to gather information about the client’s proposed endeavor for the foreseeable future and prove that it was within his capacity to conduct this research.
We were able to find that he wanted to continue his research on uncovering the cellular pathways and mechanisms involved in DNA integrity and damage repair in order to target specific tumor cells and develop more effective cancer treatments. Thus it quickly became apparent that his proposed endeavor is of great importance because it widely addresses the pathogenesis of cancer. His work was in fact indispensable to the greater understanding of cancer progression and to the development of improved treatment measures for this disease. It was because of this that his work was directly in line with national recommendations for improving cancer immunotherapy treatments. And due to its clear national importance, his research has been supported with funding from the Leukemia and Lymphoma Society (LLS) and the Italian Association for Cancer Research (AIRC).
On the other hand, we showed his academic excellence through his publication history and citation count, etc. We found that his research had resulted in 8 peer-reviewed journal articles (4 first-authored), 1 peer-reviewed editorial, and 1 first-authored book chapter. At the same time, these publications had also been cited a total of 265 times according to Google Scholar. We also said that he had been invited to conduct reviews for prestigious magazines 4 times in the past. These facts were then supported by 2 letters of recommendation, one each from a dependent and independent source.
It makes us proud to hear about the success of his case at USCIS. We wish him all the luck in any future endeavors.